Document Classification

Section Type: METHODS

Text: Overall, 115 patients received DC (docetaxel 75 mg/m (2) and cisplatin 100 mg/m (2) both on day 1, every 3 weeks, arm A1) and 118 VC (vinorelbine 30 mg/m (2) / week on days 1 and 8 and cisplatin 100 mg/m (2) on day 1, every 3 weeks, arm B1) for six cycles, and subsequently maintained by monotherapy with docetaxel (A1) or vinorelbine (B1) with cross-over on disease progression to vinorelbine 30 mg/m (2) days 1 and 8 (A2), or docetaxel 100 mg/m (2), day 1, both every 3 weeks (B2).